Spero to receive $30 million development milestone payment from GSK Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutica...
Each year, millions of patients contract infectious diseases while in hospital. These HAIs not only lengthen hospital stays and utilize resources, such as ...
Self-collected tests performed similarly to provider-collected tests for detecting common sexually transmitted infections (STIs), according to research pre...
Transaction brings Qunol®, a trusted, profitable double-digit growth and market-leading brand in health & wellness to Sanofi’s CHC U.S. por...
SKYCLARYS® recently approved in US as the only treatment indicated for patients with Friedreich’s ataxia Proposed acquisition ...
InSilicoTrials, a leading provider of artificial intelligence (AI) and simulation tools for drug and medical device development, has embarked on a ...
Hyro, the leader in conversational artificial intelligence (AI) for healthcare, today announced a partnership with Gozio Health, an industry-leading, custo...
"The FDA continues to seek new ways to advance science to address the public health challenges that families and communities across the country face," said...
Through TrialHub's data intelligence gathering platform, EmVenio can easily identify optimal markets to attract clinical trial participants who are needed ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced that the companies have agreed ...
New service leverages speech recognition and generative AI to automatically create preliminary clinical documentation from patient-clinician conversations ...
Analyses Show Oral Bridging Maintains Virologic Suppression When Subcutaneous Lenacapavir Doses are Missed – Gilead Sciences, Inc. (Na...
IntelGenx Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") announced the execution of a Research Grant Agreement with Karolinska Unive...
SQZ Biotechnologies Company (OTC: SQZB) (the “Company” or “SQZ”) announced that Roche has determined that it will not exercis...
© 2025 Biopharma Boardroom. All Rights Reserved.
